Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 64,520 | 64,281 | 50,814 | 28,202 | 13,556 |
| Depreciation Amortization | 72,191 | 52,394 | 36,753 | 23,082 | 19,514 |
| Income taxes - deferred | 3,205 | 6,014 | 3,883 | 3,069 | -1,130 |
| Accounts receivable | 7,404 | -10,492 | -3,842 | -10,390 | 7,243 |
| Other Working Capital | -9,401 | -3,719 | -3,594 | -3,055 | 1,322 |
| Other Operating Activity | -13,733 | -1,648 | -11,909 | 1,516 | -9,707 |
| Operating Cash Flow | $124,186 | $106,830 | $72,105 | $42,424 | $30,798 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -279,135 | -480,297 | -461,103 | -174,908 | -7,684 |
| Sale Of Investment | N/A | 10,320 | 24,886 | 12,367 | 5,840 |
| Other Investing Activity | 12,329 | 8,758 | 6,080 | 5,333 | 5,532 |
| Investing Cash Flow | $-266,806 | $-461,219 | $-430,137 | $-157,208 | $3,688 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 558,401 | 135,800 | 15,000 |
| Debt Issued | 588,870 | 1,035,381 | N/A | N/A | 11,345 |
| Debt Repayment | -406,961 | -699,161 | N/A | N/A | -4,559 |
| Common Stock Issued | 1,819 | 51,543 | N/A | 22,353 | 0 |
| Other Financing Activity | -11,627 | -29,680 | -200,353 | -43,133 | -70,793 |
| Financing Cash Flow | $172,101 | $358,083 | $358,048 | $115,020 | $-49,007 |
| Exchange Rate Effect | -1,411 | -101 | -331 | -335 | 478 |
| Beginning Cash Position | 17,671 | 14,078 | 14,393 | 14,492 | 28,535 |
| End Cash Position | 45,741 | 17,671 | 14,078 | 14,393 | 14,492 |
| Net Cash Flow | $28,070 | $3,593 | $-315 | $-99 | $-14,043 |
| Free Cash Flow | |||||
| Operating Cash Flow | 124,186 | 106,830 | 72,105 | 42,424 | 30,798 |
| Capital Expenditure | -312,204 | -524,603 | -491,927 | -206,830 | -31,353 |
| Free Cash Flow | -188,018 | -417,773 | -419,822 | -164,406 | -555 |